PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-7.45%
Negative revenue growth while 3141.T stands at 4.50%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-3.98%
Negative gross profit growth while 3141.T is at 5.12%. Joel Greenblatt would examine cost competitiveness or demand decline.
-17.81%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-20.34%
Negative operating income growth while 3141.T is at 0.84%. Joel Greenblatt would press for urgent turnaround measures.
-18.30%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-18.29%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-18.29%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
4.35%
10Y revenue/share CAGR under 50% of 3141.T's 31.60%. Michael Burry would suspect a lasting competitive disadvantage.
4.35%
5Y revenue/share CAGR under 50% of 3141.T's 31.60%. Michael Burry would suspect a significant competitive gap or product weakness.
-22.63%
Negative 3Y CAGR while 3141.T stands at 31.06%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
84.25%
Below 50% of 3141.T's 228.93%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
84.25%
Below 50% of 3141.T's 228.93%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
3.41%
Below 50% of 3141.T's 60.02%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
37.80%
10Y equity/share CAGR at 50-75% of 3141.T's 55.00%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
37.80%
5Y equity/share CAGR at 50-75% of 3141.T's 55.00%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
-6.14%
Negative 3Y equity/share growth while 3141.T is at 49.52%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-10.53%
Firm’s AR is declining while 3141.T shows 9.28%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
11.89%
We show growth while 3141.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
6.36%
Asset growth at 50-75% of 3141.T's 8.97%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
5.37%
1.25-1.5x 3141.T's 3.87%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
307.59%
Debt growth far above 3141.T's 19.63%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
2.63%
We expand SG&A while 3141.T cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.